Biomed 2016 Program Overview
For further information and timeslots of the program, please view each day page of the conference.
| TUESDAY, MAY 24, 2016 | |||
| 07:30-17:00 | Registration Open | ||
| 09:00 - 09:20 | Welcome Ruti Alon, General Partner, Pitango Venture Capital, IATI Biomed Co-Chairperson Dr. Benny Zeevi, Managing General Partner, Tel Aviv Venture Partners, IATI Biomed Co-Chairperson Yaky Yanay, President, Pluristem and IATI Co-Chairperson | ||
| 09:20-10:00 | Opening Keynote Lecture: Patrick Terry, President, GMPO Orphan and Sharon Terry, President and CEO of Genetic Alliance interviewed by Dana Weiss, Anchor and Senior Correspondent, Israel's Channel 2 News | ||
| 10:00-10:40 | Keynote Lecture: Francois Maisonrouge, Senior Managing Director, Evercore Partners - ''The recent market correction in Health Care: a reflection of changing fundamentals?'' | ||
| 10:40-11:10 | Coffee Break | ||
| 11:10-17:30 | The Promise of Immuno-Oncology Hall A | Neurological Disorders Hall B | Early Stage Challenges and Opportunities Hall C |
| Chairperson: Prof. Gal Markel, MD, PhD, Sheba Medical Center - ''Immuno-oncology innovations from a research medical center'' | Jay D Kranzler, VP and Global Head, External R&D Innovation – Biotherapeutics and Strategic Investments, Pfizer, Inc. - ''CNS Therapeutics: From Starting Point to Tipping Point'' | Chairperson: Assaf Barnea, CEO, Sanara Ventures | |
| Dr. Arie Belldegrun, MD, Chairman, President & Chief Executive Officer, Kite Pharma - "Engineered T cell Immunotherapy: The future is here" | Henry O Gosebruch, Executive Vice President and Chief Strategy officer, Abbvie - ''The Starting Point: The CNS Ecosystem as it Stands Today'' | Jeroen Tas, CEO, Connected Care & Health Informatics, Philips | |
| Loic Vincent, Head, Oncology External Innovation,Strategy, Science Policy & External Innovation, Sanofi - “Out of The Box Immuno-Oncology” | Tetsuyuki Maruyama, Chief Scientific Officer, Dementia Discovery Fund - ''New Financing Vehicles: The Dementia Discovery Fund Example'' | Dr. Wei Siang Yu, Healthcare Futurist, Founder and Executive Chairman of Borderless Healthcare Group | |
| Company Presentations | Prof. Michal Schwartz, the Maurice and Ilse Katz Professorial Chair in Neuroimmunology, Weitzmann Insititute - ''New Scientific Paradigms: Inflammation in Neurodegenerative Disease - Friend or Foe?'' | Round Table Discussions: 1. Alternative Financing Models: Jon Medved, Founder and CEO, OurCrowd James Rogers III, J.D. The chair of Mayo Clinic Ventures David Revcolevschi, Partner, Paul Hastings Anya Eldan, GM of Early Stage Companies and Incubators, Israel Innovation Authority Dana Chanan,CEO , Sweetch Galit Zuckerman, CEO, Medasense Evan Norton , Divisional Vice President, Venture Investments at Abbott Ventures Nissim Darvish, MD, PhD, Senior Managing Director, OrbiMed | |
| 13:30-14:30 | Lunch Break | ||
| Compugen Ltd. | Daniel R. Karlin, MD, MA, Senior Director, Pfizer Inc. | 2. Introducing Innovation into Developing Countries: Dr. Yehoshua (Shuki) Gleitman, Chairman of GIBF (Global Independent Baptist Fellowship) Avinoam Sapir, CEO, Teva Israel & Head of Innovation Growth Markets Eddy Horowitz, CEO, Circ MedTech Ariel Ikan, CEO, Philips Health Care, Israel Seth Salpeter, Chief Science Officer & VP Business Development, Sight Diagnostic Healthcare Futurist, Founder and Executive Chairman of Borderless Healthcare Group Nadav Kidron, CEO, Oramed Prof. Pinny Halperin, Associate Professor of Emergency Medicine, Chair of Emergency, Tel Aviv Medical Center | |
| BioLineRx Ltd. | Miri Polachek, Executive Director at Israel Brain Technologies - ''Status of Israeli Braintech – Current and Future'' | Round Table Discussions: 3. From Sickcare to Healthcare: Michael Tal, Founder of Lacrima Medical Assaf Sella, CEO, Kytera Technologies Yoram Feldman, Director of ReAbility Tele-Rehab Technologies at Gertner Institute Dr. Yair Birnbaum, Chief Medical Officer of Clalit Healthcare Services Gil Adato, VP, Head of Business Development & Connected Value Propositions Connected Digital Platforms & Propositions (CDP2), Royal Philips Elad Bassan, Operations Manager, Teva Amir Kesten, Director, Teva | |
| Vascular BioGenics Ltd. | Amir Amedi, Associate Professor of Medical Neurobiology and Cognitive Sciences, Hebrew University of Jerusalem - ''Academic Research – New frontiers in rehab medicine by combining sensory substation with bionic prostheses'' | 4. Introducing Unique Points of Care: Mark Coticchia, Vice President and Chief Innovation Officer, Henry Ford Health System Dr. Scott Dulchavsky, CEO of The Henry Ford Innovation Institute and also serves as the Roy D. McClure Chairman of Surgery and the Surgeon in Chief at Henry Ford Hospital in Detroit Dr. Dalit Landesman, Chief Biologist, Biopmedical Efrat Marmur, Head of Innovation Technologies and Services ,Teva Israel Dr. Itamar Offer, Head of Israel's leading private hospital Hertzeliya Medical Center Avner Halperin, CEO, Earlysense John Milad, CEO, Quanta Fluid Solutions | |
| Silenseed Ltd. | Established Company Panel Panelists: Ronen Gadot, Chief Executive Officer, Elminda Guy Ezekiel , CEO, Brainsway Yaron Danieli, CEO, Alcobra | ||
| Kahr Medical Ltd. | ALS Analyzer | ||
| Efranat Ltd. | NIBS Neuroscience | ||
| Immune Oncology Pharmaceuticals | Neurosteer | ||
| Panel Moderator: Dr. Luisa Salter-Cid, Vice-President, Immunoscience, Bristol-Myers Squibb Panelists: Prof. Gal Markel MD, PhD, Sheba Medical Center Dr. Anat Cohen-Dayag, President and CEO of Compugen Prof. Yoram Reiter, Head of Molecular Immunology Lab, Technion Aya Jakobovits, CEO , Adicet Bio | |||
| 17:30-19:00 | Gala Event | ||
| WEDNESDAY, MAY 25, 2016 | |||
| 08:00-16:00 | Registration Open | ||
| 09:30-10:10 | Keynote Lecture: Bruce R. Rosengard, MD, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies | ||
| 10:10-10:40 | Coffee Break | ||
| 10:40 - 17:45: | Personalized Diagnostics and Precision Medicine Hall A | Listen to Your Aching Heart Hall B | From Academia Research to Industry Hall C |
| Chairpersons: Patrick Terry, President, GMPO Orphan and Dr. Eran Eden, PhD, CEO and Co-Founder, MeMed Diagnostics Ltd. | Chairperson: Dr. Ehud Cohen, CEO BioControl | Chairperson: Shlomo Nimrodi, CEO, Ramot at Tel Aviv University Ltd. | |
| Patrick Terry, President, GMPO Orphan - "Percision Medicine - Then and Now" | Donald E. Bobo, Corporate Vice President, Heart Valve Therapy, Corporate Strategy & Corporate Development, Edwards Lifesciences - "Cardiovascular Devices - Where is the Future Taking Us?" | Shlomo Nimrodi - CEO of Ramot - Ramot at Tel Aviv University, Promising Innovations- The impact of academic research on the Israeli eco system | |
| Dr. Eran Eden, PhD, CEO and Co-Founder, MeMed Diagnostics Ltd. - ''Opportunities and Challenges in Personalized Diagnostics - A Journey from an Idea to the Patient Bedside'' | Industry perspective - Rabbi Raphael Harrari - Steba BioTech | ||
| ITTN Startup Competition: BELKIN Laser Ltd. CartiHeal ElMindA Ltd. HBMS MagBiosense, Inc. | |||
| NovellusDx Ltd. | Dr. Anthony (Tony) Muslin, Vice President, Head of Cardiovascular and Fibrosis, Sanofi - “Opportunities and Challenges in the Cardiovascular Biopharma Market.” | ITTN Startup Competition - Continues: MBcure Nitiloop Ltd Pam-Bio Ltd. SynVaccine Ltd TyrNovo Ltd. | |
| ImmunArray Ltd. | 11:30 - 12:10: Dr. Anthony (Tony) Muslin, Vice President, Head of Cardiovascular and Fibrosis, Sanofi - “Opportunities and Challenges in the Cardiovascular Biopharma Market.” | ||
| LabStyle Innovations Corp. | Magenta Medical | ||
| CureWize Health Ltd. | DiACardio Ltd. | ||
| Sensible Medical Innovations Ltd. | |||
| 13:00-14:00 | Lunch Break | ||
| Hide and Seq | Realview Imaging Ltd. | Inspiring future medicine- From Bench to bedside Erez Meltzer, Chairman ,Hadassah Hospital and Hadasit, the Technology Transfer Company of Hadassah Medical Organization | |
| Medasense Biometrics Ltd. | Pluristem Therapeutics Inc. | Big Data in Healthcare: Dr. Liran Shlush, Department of Immunology, Faculty of Biology, Weizmann Dr. Ran Balicer, Director, Health Policy Planning & Director,Clalit Research Institute at Clalit Health Services Chaim Friedman, Managing Partner, LionBird – Venture Capital | |
| Sight Diagnostics, Ltd. | ChroniSense Medical Ltd. | Oncology, Cancer Therapy - Current needs and emerging capabilities: Prof. Michal Lotem, Head of Hadassah’s Center for Melanoma and Immunotherapy Prof. Izhak Haviv, Faculty of Medicine, Bar Ilan University Prof. Dan Peer, Cell Research and Immunology, Tel Aviv University | |
| Manish Kohli, MD, Mayo Clinic - “Applications of Genomic Sciences in Advanced Stage Prostate and Kidney cancer: Opportunities and Challenges in 2016” | V-Wave Ltd. | Robotics’ Role in Rehabilitation: Dr. Gabi Zeilig, Director of the Department of Neurological Rehabilitation, The Chaim Sheba Medical Center Dr. Orit Raz - The Chaim Sheba Medical Center Dr. Arik Avni – VP Clinical Affairs at Motorika Medical Israel | |
| Miro Venturi, PhD, Global Head Diagnostics Biomarkers, Hoffmann-la Roche - "The importance of diagnostics and molecular information in the patient's journey: realizing the promise of personalized healthcare" | Eximo Medical Ltd. | Neurological Disorders- from Pessimism to Hope: Dr. Yona Geffen, CEO of Avraham Pharmaceuticals Prof. Abraham Zangen, Head of the Brain Stimulation and Behavior lab at Ben Gurion University | |
| Harry Glorikian, Entrepreneur in Residence, GE - ''The Future of Precision Medicine'' | Enopace Biomedical Ltd. | Announcement of startup competition winners | |
| Panel Discussion Patrick Terry, President, GMPO Orphan Dr. Eran Eden, PhD, CEO and Co-Founder, MeMed Diagnostics Ltd. Manish Kohli, MD, Mayo Clinic Miro Venturi, PhD, Global Head Diagnostics Biomarkers, Hoffmann-la Roche Harry Glorikian, Entrepreneur in Residence, GE | Amir Lerman, MD, Prof. of Medicine, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic - "The pathways for creating a biological valve" | ||
| Panel Discussion Moderator: Dr. Ehud Cohen, CEO BioControl Panelists: Donald E. Bobo, Corporate Vice President, Heart Valve Therapy, Corporate Strategy & Corporate Development, Edwards Lifesciences Dr. Anthony (Tony) Muslin, Vice President, Head of Cardiovascular and Fibrosis, Sanofi Amir Lerman, MD, Prof. of Medicine, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic Hila Goldman-Aslan, CEO, Dia Cardio Ltd. | |||
| THURSDAY, MAY 26, 2016 | |||
| 08:30-15:00 | Registration Open | ||
| 09:00-09:20 | Avi Hasson, Chief Scientist of the Ministry of Economy of the State of Israel | ||
| 09:20-10:00 | Keynote Lecture: Patrick Figgis, Global Leader for Health Industries, PwC -"The New Health Era: The impact of New Entrants" | ||
| 10:00-10:40 | Keynote Lecture: Dr. Dario Gil, Vice President, Science and Solutions, IBM Research, T.J. Watson Research Center, Yorktown Heights, New York- "Cognitive solutions for healthcare - from foundational science to internet of things" | ||
| 10:40-11:10 | Coffee Break | ||
| 11:10-17:30 | Health IT Hall A | The New "Kids" on the Block: Gene Editing and Gene Therapy Hall B | Robotics’ Role in Healthcare Hall C |
| Chairpersons: Dr. Michal Rosen-Zvi, Director, Health Infomatics, IBM Research and Yael Glassman, President, Nutrino | Chairperson: Dr. Adi Barzel, PhD, Co-Founder and CSO, LogicBio Therapeautics | Chairperson: Prof. Alon Wolf, Technion, Israel Institute of Technology and Harel Gadot, CEO & Company Group Chairman, MEDX Ventures Group | |
| Prof. Mads Melbye, MD, DMSc, Executive Vice President, Statens Serum Institut, Division of Epidemiology and Disease Surveillance & The Danish National Biobank, Denmark- “The Danish National Biobank and health registers: A gold mine for research” | Dr. Adi Barzel, PhD, Co-Founder and CSO, LogicBio Therapeautics | Introduction: Prof. Alon Wolf, Director Biorobotics and Biomechanics Lab, Technion Israel Institute of Technology - "From the Class Room to the Operating Room: Bringing Robotics Ventures to Life" A Case Study: Ori Hadomi, CEO, Mazor Robotics Ltd. | |
| Panel Discussion: Imaging Analysis Moderator: Michal Rosen-Zvi, Director, Health Infomatics, IBM Research Panelists: Zebra Medical, Medymatch, TailorMed, IBM | Emendo Biotherapeutics | Dr. Sanjeev Dutta, Vice President Therapeutic Area Expert in Robotics and MIS, Johnson & Johnson Medical Device Companies - "The Future of Medical Robotics - A Corporate View" | |
| Company Presentations | Medgenics Inc. | XACT Robotics Ltd. | |
| Panel Discussion: Stephen E. Yoder, MD, MBA, Head, Specialty Pharmaceuticals Search & Evaluation, Business Development at Bristol-Myers Squibb Professor Zelig Eshhar, Department of Chemical Immunology, Weizmann Institute of Science and Tel Aviv Sourasky Medical Center LogicBio, EmendoBio and MedGenics | |||
| 12:50-13:50 | Lunch Break | ||
| Michael Fahey, Offering Manager for Exogenous Data at IBM Watson Health - “The Growing Role of Exogenous Data in Healthcare” | The New "Kids" on the Block: Microbiome Hall B Chairperson: Prof. Zamir Halpern MD, Tel Aviv Sourasky Medical Center and Nitsan Maharshak, MD, Head of Bacteriotherapy Clinic, Department of Gastroenterology and Hepatology, Tel Aviv Medical Center | Dr. Marco A. Zenati, MD, MSc, FETCS, Professor of Surgery, Harvard Medical School - "The Future of Medical Robotics - An Academic View" | |
| Panel Discussion: Patients’ Behavior Moderator: Yael Glassman, President, Nutrino Panelists: Teva, Valera Health, Feurstein Institute, Philips, Medisafe | Prof. Zamir Halpern, MD, Tel Aviv Sourasky Medical Center - "The microbiome in medicine- emergence of new insights into diseases' pathogenesis" | Jonathan Sorger, Senior Director of Medical Research, Intuitive Surgical - "From A to Z: Commercializing a Robotics Company" | |
| 2bPrecise | Nitsan Maharshak, MD, Head of Bacteriotherapy Clinic, Department of Gastroenterology and Hepatology, Tel Aviv Medical Center - "Enteric Microbial Therapy- from Fecal Microbial Transplantation to Challenges of the Future" | Microbot Medical Ltd. | |
| Kytera Technologies | RondinX Ltd. | Roboscopy Ltd. | |
| Efficacy Care | Day Two Ltd. | Memic Ltd. | |
| MedAware | MyBiotics Pharma Ltd. | MST - Medical Surgery Technologies Ltd. | |
| Ocean Process A/S | MBcure Ltd. | Panel: Moderator: Harel Gadot, CEO & Company Group Chairman, MEDX Ventures Group Panelists: Prof. Alon Wolf, Director Biorobotics and Biomechanics Lab, Technion Israel Institute of Technology Jonathan Sorger, Senior Director of Medical Research, Intuitive Surgical Dr. Marco A. Zenati, MD, MSc, FETCS, Professor of Surgery, Harvard Medical School Dr. Sanjeev Dutta, Vice President Therapeutic Area Expert in Robotics and MIS, Johnson & Johnson Medical Device Companies Bruce R. Rosengard, MD, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Device Companies Yoram Maaravi, M.D, Senior Physician at the Department of Geriatric Medicine and Rehabilitation of the Hadassah-Hebrew University Medical Centers Tamar Flash, PhD.Professor at the Department of Computer Science and AppliedMathematics, Weizmann Institute of Science | |
| EarlySense | Panel Discussion: Moderator: Yehuda Ringel, MD, AGAF, FACG, Professor of Medicine, Division of Gastroenterology, Rabin Medical Center (RMC), Beilinson Hospital Panelists: Marie Lindner, MD, Global Program Head, Strategic Partnership Team, Novartis Michael Berman, Chairman and Co-Founder, Rebiotix Dr. Luisa Salter-Cid, Vice-President, Immunoscience, Bristol-Myers Squibb Prof. Zamir Halpern MD, Tel Aviv Sourasky Medical Center | ||
| HOME TRAX | |||
| iFeel Labs |